What is it about?

PCL filler with lidocaine because not enough time may be available for the lidocaine solution to act and produce an immediate effect on pain control. The most important step in this method is the pre-mixing, which can change the properties of the original filler, especially that of the filler’s CMC constituent. The properties of the CMC gel are decided by the proportions of constituent water and glycerin. If the proportion of water were increased, gel viscosity consequently decreases, and its original function as carrier gel is lost. Depending on time, temperature and pH, a CMC gel is easily contaminated by microbes or molds and there few studies proving the safety of adding normal saline to CMC gels are available. Therefore, in my simple and novel technique, tumescent solution is injected, followed by PCL filler which preserves the original CMC property. This is done after sedation of the tissue by the tumescent solution and dissection of soft tissue to create a space for the ensuing PCL injection. After pre-injection (test-injection or hydro-dissention injection) with tumescent solution, histological analysis indicated that the tissue was not irritated by the foreign body material (PCL filler) or mechanical trauma caused by the needle. This is the key mechanism for reducing tissue reactions in the tumescent injection method, and may also reduce pain and swelling during and after PCL filler injections. 10 minutes after injection of tumescent solution, the solution will undergo spread and volume change will be minimized. Therefore, it is not necessary to worry about volume change after treatment with tumescent solution.

Featured Image

Why is it important?

Important differences in, pain, edema, and ecchymosis were observed between treatment by PCL Injection after pre-injection with tumescent solution (left side of face) and pre-mixing PCL filler with lidocaine (right side of face). Severe swelling (mean score, 4.8), pain (mean score, 4.7) and ecchymosis (mean score, 4.2) were observed after premixing PLC with lidocaine in the right side of the face. Most injected areas on the left side show fewer signs of swelling (mean score, 3.2), pain (mean score, 2.4), and ecchymosis (mean score, 2.7) (Table 1, Figure 1). Swelling, pain, and ecchymosis were significantly reduced in the areas injected with PCL filler after tumescent solution anesthesia on the left side. The tumescence anesthesia method prevented edema and pain after the injection of the PCL filler. No significant long-term differences were observed between the left and right sides, but there were differences in initial swelling and ecchymosis. Thus, it may be concluded that the efficacy of Ellansé was not compromised by this new method, and that it was associated with a less intense immediate tissue reaction and a reduced inflammatory reaction, as confirmed by the histological analysis of biopsy samples and clinical findings.

Perspectives

With regards to collagen formation after filler (stimulator) injection, the amount of neovascular formation depends on the patient and the injection area. The volume graph provided by AQTIS (now Sinclair pharma) was not applicable to most patients because the initial volume loss from the CMC portion of the filler (CMC gel is absorbed 1 or 2 months after injection) was not reflected in the company’s disseminated data. Some physicians demonstrated with computer scanning programs that the volumization effect was maintained over 1 year but this was not the usual clinical progression of the procedure. CMC could not be replaced by soft tissues after injection in the author’s own studies.6 The author is conducting further analysis of PCL fillers with H&E, PSR, Herovici’s stain and immunochemistry antibody staining. The key to maintaining volume after the injection of PCL filler is the formation of new vascular tissue and stimulation of collagen production. Booster injections with PDRN or PRP can promote vascular tissue stimulation, but initial volume loss after injection must have occurred as the CMC portion can be absorbed even while new collagen or soft tissues are growing.

Plastic Surgeon Jongseo Kim
American Society for Aesthetic Plastic Surgery

Read the Original

This page is a summary of: Tumescent anesthesia for reducing pain, swelling, and ecchymosis during polycaprolactone filler injections in the face, Journal of Cosmetic and Laser Therapy, June 2017, Taylor & Francis,
DOI: 10.1080/14764172.2017.1342037.
You can read the full text:

Read

Contributors

The following have contributed to this page